GlobalData on MSN5mon
Travere pauses enrolment in Phase III homocystinuria treatment trialTravere Therapeutics has voluntarily paused subject enrolment in the Phase III HARMONY Study of pegtibatinase to treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback